Biotech News

Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference

Unicycive Therapeutics (UNCY)Unicycive Therapeutics2026-06-25 13:46 ESTConference / presentation

UNCY (UNCY) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is uncy.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics to Participate in Upcoming Investor Events in December

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update

UNCYUnicycive Therapeutics2026-06-25 13:46 EST

Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

View all latest news

Unicycive Therapeutics

Unicycive Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Recent company news

UNCYUnicycive Therapeutics2026-06-26 14:47 EST

Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

UNCYUnicycive Therapeutics2026-06-26 14:47 EST

Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference

UNCYUnicycive Therapeutics2026-06-26 14:47 EST

Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference

UNCYUnicycive Therapeutics2026-06-26 14:47 EST

Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

UNCYUnicycive Therapeutics2026-06-26 14:47 EST

Unicycive Therapeutics to Participate in Upcoming Investor Events in December

Stock data

Close: —
Market cap: —
Exchange: NASDAQ
Sector: Biotechnology
Location: United States